Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome11See Editorial by Abbate and Remuzzi, p. 764.
Authors:
- Bogdan BeirowskiBBBogdan Beirowski
- Marie-Louise KoepkeMKMarie-Louise Koepke
- Jeannine KuckJKJeannine Kuck
- Michael ReinerMRMichael Reiner
- Klaus AddicksKAKlaus Addicks
- Neil SmythNSNeil Smyth
- Eckhard Schulze-LohoffESEckhard Schulze-Lohoff
- Manfred WeberMWManfred Weber
- 1 February 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (2) , 438-446
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counsellingNephrology Dialysis Transplantation, 2002
- Angiotensin II and Renal FibrosisHypertension, 2001
- Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathyKidney International, 2000
- Role for transforming growth factor-β1 in Alport renal disease progressionKidney International, 1999
- Long-term effects of cyclosporine A in Alport's syndromeKidney International, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trialThe Lancet, 1998
- Alport Syndrome: Clinical and Genetic Correlation in a Type-IV Collagen Disease1997
- Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.Genes & Development, 1996
- HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITISBMJ, 1927